Determination of aranidipine and its active metabolite in human plasma by liquid chromatography/negative electrospray ionization tandem mass spectrometry

A simple, sensitive and rapid high-performance liquid chromatography/negative electrospray ionization tandem mass spectrometry method was developed and validated for the assay of aranidipine (AR) and its active metabolite (AR-M) in human plasma. Following a liquid-liquid extraction, the analytes were separated using an isocratic mobile phase on a reversed-phase column and analyzed by mass spectrometry in the multiple reaction monitoring mode using the respective [M-H](-) ions, m/z 387.0 -> 164.0 for AR, m/z 389.1 -> 208.1 for AR-M and m/z 359.0 -> 121.8 for the internal standard. The assay exhibited a linear dynamic range of 0.02-10 ng.mL(-1) for AR and 0.2-100 ng.mL(-1) for AR-M in human plasma. The limits of quantitation were 0.02 ng.mL(-1) for AR and 0.2 ng.mL(-1) for AR-M. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. A run time of 2.8 min for each sample exhibited its high-throughout analysis ability. The validated method can be applied to analyze human plasma samples for pharmacokinetic studies. Copyright (c) 2006 John Wiley & Sons, Ltd.